Exciting times ahead.
Trofinetide action over the next 10 months will be huge - 10 months of action ahead of us there.
- and NNZ2591 is even more promising and is a "superior drug" according to Jon.
And we currently own 100% of NNZ2591.
Treatment for all of these ailments using Neuren's drugs will be a fantastic achievement.
In my opinion this company is cashed up and substantially de-risked.
Neuren will get a lot of interest over the next 12-18 months.
Best position ever ., page-13
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.80 |
Change
-0.830(5.31%) |
Mkt cap ! $1.891B | |||
| Open | High | Low | Value | Volume |
| $15.65 | $15.72 | $14.76 | $11.61M | 772.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1392 | $14.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.90 | 1553 | 2 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |